Life Sciences Tools and Services
Company Overview of Myriad RBM, Inc.
Myriad RBM, Inc., a multiplexed immunoassay testing laboratory, provides protein biomarker services based on its proprietary multi-analyte profiling (MAP) technology platform for the life sciences industry. The company offers reproducible and quantitative multiplexed immunoassay data for various proteins from a single drop of blood serum or plasma to clinical researchers, physicians, and healthcare providers to advance their drug development and patient care. Its products and services include human MAPs that provide insight into multiple pathways to understand the underlying biology; rodent MAPs that provide quantitative measurement of biomarkers enabling new pattern discovery, and sensitive...
3300 Duval Road
Austin, TX 78759
Founded in 1998
Key Executives for Myriad RBM, Inc.
Managing Director and Chief Scientific Officer of EDI GmbH
Compensation as of Fiscal Year 2013.
Myriad RBM, Inc. Key Developments
DVA Laboratory Services, Inc. and Myriad RBM, Inc. Announce Biomarker Research Collaboration
Jun 17 13
DVA Laboratory Services, Inc. and Myriad RBM announced a research collaboration to conduct protein biomarker discovery research with the goal of developing and commercializing diagnostic tests that could benefit in the treatment of dialysis patients. DaVita and Myriad have identified potential opportunities where novel diagnostic tests utilizing blood-based protein biomarkers could improve the quality of life for patients and potentially lower overall healthcare costs. The primary area of focus will include the prediction of vascular access failure.
Bio-Rad Laboratories, Inc. and Myriad RBM, Inc. Partner to Commercialize Multiplex Biomarker Kits for Life Science Research
Jul 24 12
Bio-Rad Laboratories, Inc. and Myriad RBM, Inc. announced that they have partnered to develop and distribute high-quality immunoassay kits. Under the terms of the agreement, Myriad RBM grants Bio-Rad exclusive distribution rights, for research purposes, to the largest catalog of quantitative multiplexed immunoassays currently available to run on the Bio-Plex 200, Bio-Plex 3D, and Bio-Plex MAGPIX instruments. Myriad RBM's assays address researchers' needs for multiplex testing of samples with very low volumes when studying toxicology, oncology, immunology, and cardiovascular and other diseases. The new assays expand Bio-Rad's current suite of assays.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries